Does Successful Cancer Treatment Consist Only of Extending Lifespan?

Modern, that is, evidence-based cancer treatments are viewed negatively by many people. The most common prejudice is that "even if oncological treatments extend lifespan, they impair quality of life". In fact, many new cancer treatments not only extend lifespan but also preserve, and even improve, quality of life and the patient's daily activities / functioning. Journal of Oncology Practice published, on 19 July 2019, a study, showing that, for patients with advanced lung cancer , successful treatment not only increases survival but also preserves quality of life.
When asked before starting chemotherapy, most patients (% 60.4) were found to define treatment as more than survival alone. Patients not only want to live longer but also want a good quality of life, to achieve personal goals and / or spend time with family and friends.
However, as their treatment progressed, nearly half of patients (% 47) changed their definitions of success. For example, among patients who initially defined treatment success as survival alone, % 80 now defined it as a combination of survival and quality of life.
"The study findings may be useful in improving patient care by enhancing physician-patient communication and identifying patients' expectations and treatment options." says the study's author, Dr. K.M. Islam, Professor of Epidemiology at Augusta University's Medical College of Georgia.
Today, metastatic (advanced) lung cancer has rapidly increasing treatment options, but no known treatment provides a complete cure. Currently used chemotherapy regimens and immunotherapies, are successful in managing cancer signs and symptoms and extending survival, but have similar efficacy. Therefore, in patients with advanced non-small cell lung cancer (KHDAK), the primary aim of treatment is generally to extend the patient's life.
However, to date, in a group of patients with advanced lung cancer, treatment success from the patient's perspective has not been defined in any study comparing other factors such as "survival alone" versus "survival plus quality of life".
More Than Survival
The study was conducted between January 2014 and April 2016 at eight cancer centers in the US Midwest and one center in Florida.
The study included 235 patients with advanced non-small cell lung cancer, with a maximum of three interviews per participant: before, during and after first-line chemotherapy. The patients' mean age was 68.
At the first interview, % 60 of patients defined treatment success as more than survival, and approximately one-quarter of the group (% 23) defined it as a good quality of life. Among patients, % 12 defined treatment success as survival alone.
Almost all patients (% 90) who initially defined treatment success as both survival and quality of life maintained this definition at their final interviews.
Further analyses showed that, among patients who initially defined treatment success as survival alone, % 52.4 changed their definitions to include other goals and % 23.8 changed their definitions to improvement in quality of life alone.
Regarding patient characteristics, those younger than 60 and those not working tended to define treatment success as survival alone. Multivariable analyses showed that women, those aged 61-70 and married patients were more likely to define treatment success as survival plus quality of life (however, these differences were not statistically significant).
Among participants who changed their definition of treatment success, % 60 had not received a university education, and more than half of patients who changed their definition were Medicare beneficiaries (note: Medicare is government-provided national health insurance for US citizens older than 65).
Islam and colleagues "A patient's definition of treatment success may be a dynamic that changes as treatment continues and is relevant to maintaining patient-physician communication throughout clinical care." commented. In conclusion, modern cancer treatments allow many patients to achieve survival that was not possible in the past, while longer lifespans also make quality of life an important component of cancer care.
Let us end this article with a quote from Alexis Carrel, one of the first physicians to define "quality of life" in medicine. Nobel laureate Dr. Carel, who left his mark on the first half of the 20th century and is considered the father of vascular surgery and therefore organ transplantation (1873-1944), "Quality of life is more important than life itself." made a statement that had a major impact on the medical world.
Sources
Patient-Defined Treatment Success: Perspectives of Patients With Advanced-Stage Lung Cancer.
Journal of Oncology Practice - Published online 19 July 2019.
Was this article helpful?
Your feedback helps us improve our content.





Reader comments
Share your comment
Your name and comment are published only after administrator approval. Your email address is never shown to visitors.
Be the first to comment.